trial < trials < trichophagia

Facettes :

List of bibliographic references indexed by trials

Number of relevant bibliographic references: 45.
[0-20] [0 - 20][0 - 45][20-40]

Ident.	Authors (with country if any)	Title
000149 (2015)	Anette Schrag [Royaume-Uni] ; Anna Sauerbier [Royaume-Uni] ; Kallol Ray Chaudhuri [Royaume-Uni]	New clinical trials for nonmotor manifestations of Parkinson's disease.
000331 (2015)	Karl Kieburtz [États-Unis] ; C Warren Olanow [États-Unis]	Advances in clinical trials for movement disorders.
000406 (2014)	Edward J. Wild ; Sarah J. Tabrizi	Targets for future clinical trials in Huntington's disease: What's in the pipeline?
000527 (2014)	Elizabeth H. Aylward	MRI Striatal Volumes – A Biomarker for Clinical Trials in HD
000564 (2014)	Julie C. Stout [Australie] ; Sarah Queller ; Kalyca N. Baker ; Sean Cowlishaw ; Cristina Sampaio ; Cheryl Fitzer-Attas ; Beth Borowsky	HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
000639 (2014)	Cristina Sampaio [États-Unis] ; Beth Borowsky ; Ralf Reilmann	Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches.
000876 (2013)	Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox	Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
000959 (2013)	Esther Cubo [Espagne] ; Miguel González ; Harvey Singer ; E Mark Mahone ; Lawrence Scahill ; Kirsten R. Müller-Vahl ; Raul De La Fuente-Fernández ; Diana Armesto ; Katie Kompoliti	Impact of placebo assignment in clinical trials of tic disorders.
000A86 (2013)	Pankaj A. Agarwal [Canada] ; A Jon Stoessl	Biomarkers for trials of neuroprotection in Parkinson's disease.
000C54 (2012)	Johannes R. Streffer [Belgique] ; Igor D. Grachev ; Cheryl Fitzer-Attas ; Baltazar Gomez-Mancilla ; Babak Boroojerdi ; Juliana Bronzova ; Susanne Ostrowitzki ; Stephen J. Victor ; Paulo Fontoura ; Robert Alexander	Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.
000F86 (2012)	Scott Y. H. Kim [États-Unis] ; Raymond De Vries [États-Unis] ; Robert G. Holloway [États-Unis] ; Renee Wilson [États-Unis] ; Sonali Parnami [États-Unis] ; H. Myra Kim [États-Unis] ; Samuel Frank [États-Unis] ; Karl Kieburtz [États-Unis]	Sham Surgery Controls in Parkinson's Disease Clinical Trials: Views of Participants
001020 (2012)	Johannes R. Streffer [États-Unis] ; Igor D. Grachev [États-Unis] ; Cheryl Fitzer-Attas [Israël] ; Baltazar Gomez-Mancilla [Suisse] ; Babak Boroojerdi [Allemagne] ; Juliana Bronzova [Pays-Bas] ; Susanne Ostrowitzki [Suisse] ; Stephen J. Victor [États-Unis] ; Paulo Fontoura [Suisse] ; Robert Alexander [Suède]	Prerequisites to Launch Neuroprotective Trials in Parkinson's Disease: An Industry Perspective
001149 (2012)	Jordan J. Elm [États-Unis]	Design Innovations and Baseline Findings in a Long-Term Parkinson's Trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1
001161 (2012)	Scott Y. H. Kim [États-Unis] ; Renee M. Wilson [États-Unis] ; H. Myra Kim [États-Unis] ; Robert G. Holloway [États-Unis] ; Raymond G. De Vries [États-Unis] ; Samuel A. Frank [États-Unis] ; Karl Kieburtz [États-Unis]	Comparison of Enrollees and Decliners of Parkinson Disease Sham Surgery Trials
001251 (2011)	Ralf Reilmann [Allemagne]	Progression of premanifest and early Huntington's disease detectable after 1 year—does TRACK-HD open the door to disease-modifying trials in HD and beyond?
001286 (2011)	Dietrich Haubenberger [États-Unis, Autriche] ; Daniel Kalowitz [États-Unis] ; Fatta B. Nahab [États-Unis] ; Camilo Toro [États-Unis] ; Dominic Ippolito [États-Unis] ; David A. Luckenbaugh [États-Unis] ; Loretta Wittevrongel [États-Unis] ; Mark Hallett [États-Unis]	Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor
001419 (2011)	Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]	Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials
001430 (2011)	Julien Vezoli [France, Allemagne]	Recombinant proteins to induce pluripotent stem cells: Promises for a safer and thriving step toward clinical trials
001454 (2011)	Ralf Reilmann [Allemagne]	Progression of premanifest and early Huntington's disease detectable after 1 year—Does TRACK‐HD open the door to disease‐modifying trials in HD and beyond?
001491 (2011)	Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]	Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
001554 (2011)	C. Warren Olanow [États-Unis] ; Kathryn B. Wunderle [États-Unis] ; Karl Kieburtz [États-Unis]	Milestones in movement disorders clinical trials: Advances and landmark studies

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "trials" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "trials" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    trials
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024